This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Insmed Inc.Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics. Media Release: 12 Feb 2008. Available from: URL: http://www.insmed.com
Rights and permissions
About this article
Cite this article
Follow-on biologicals could save billions. Pharmacoecon. Outcomes News 547, 10 (2008). https://doi.org/10.2165/00151234-200805470-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805470-00033